Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy is proud to be delivering an engaging and interactive 1.5 day course to improve the professional knowledge and skills required to plan and deliver successful cardiovascular pharmacotherapy clinical trials.
- Methodological issues regarding the design, conduct and interpretation of clinical trials
- New types and trends of trials required by regulators
At the end of the course delegates will have improved their knowledge in:
This course is aimed at improving knowledge and skills related to clinical trial planning and design as well as the successful running of different types of clinical trials.
The Working Group offers highly interactive sessions coordinated by top experts in their fields. In addition, the course offers interactive workshops on Good Clinical Practice (GCP certificate included), statistics, trial data interpretation and manuscript writing.
Our goal is for all participants to leave the meeting with the improved competence and confidence to deliver better clinical trials which in turn will have a positive impact on services and patient outcomes.
This course is also an excellent opportunity for education, networking and creating opportunities.
Sven Wassmann, MD, PhD, FESCGiuseppe MC Rosano, MD, PhD, FESC
Welcome, introduction and course objectives
09:10: An overview of the different aspects of clinical trials - A. Niessner09:50: Traditional versus novel trial designing - G.M.C. Rosano10:20: Planning and organising a clinical trial - B.S. Lewis10:40: The logistics of running a clinical trial - B.S. Lewis
11:00: Refreshments and networking
11:30: Clinical trials: the sponsor´s viewpoint (industry representative)
12:00: Requirements from regulatory agencies: endpoints, comparators, type of studies - G.M.C. Rosano12:30: Post marketing surveillance - T. Walther
13:00: Lunch and networking
14:00: Observational trials and registries - G.L. Savarese 14:20: Randomised controlled trials - A. Niessner14:40: Meta-analyses and systematic reviews - G.L. Savarese
15:00: ACS / Antithrombotics - B.S. Lewis / S. Wassmann15:15: Lipidology - H. Drexel15:30: Diabetes - T. Schmidt15:45: Heart failure - G.M.C. Rosano
16:00: Refreshments and networking
16:30: GCP for the busy investigator (certificate included) - D. Rolfe
18:30: Close of day 1 - Refreshments and networking
08:00: Parallel groups (switch after 60 min):
10:00: Refreshments and networking
10:30: Examples from recent clinical trials - S. Wassmann, Panelists
12:00: Parallel groups:
12:30: S. Agewall12:45: Closing remarks - G.M.C. Rosano, S. Wassmann
13:00: Close of day 2 - Lunch and networking
Registration is open from 03 October to 04 December 2016
Working Group Member
Student / PHD
This initiative is supported by an unrestricted grant from